Several in vitro studies have shown that inhibition of PI3K/AKT pathway can sensitize a variety of other types of cancer cells to chemotherapeutic drugs [23, 24], but the effects of specific inhibitors of PI3K/AKT on esophageal cancer chemoresistance have not been reported. This evidence concerns the gene AKT1 and esophageal cancer.